Clinical evaluation of blue-light blocker foldable acrylic IOL (HMY).
Efficacy and safety of blue-light-filtering acrylic IOL (HMY) were assessed and proven from 3 months to 1 year of postoperative follow-up in a clinical study performed on 80 eyes of 45 patients. Postoperative corrected visual acuity of all the eyes was 6/12 or better and 78.8% of them achieved higher than 6/6. The rate of mean corneal endothelial cell density decrease stood at 5.0%. Mild complications were observed, but none were serious.
Hibino
Tsuyoshi
T
Department of Ophthalmology, Kinki University School of Medicine, Osaka, Japan. hibinot@kfy.bigtobe.ne.jp
Shimomura
Yoshikazu
Y
Matsumoto
Chota
C
Fukuda
Masahiko
M
Uno
Naoki
N
Usui
Masahiko
M
Takeuchi
Masaru
M
Asatani
Tetsuya
T
Minoda
Hiroshi
H
D000180:Acrylic Resins / Q000592:standards; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002387:Cataract Extraction / Q000379:methods / Q000592:standards; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019654:Lens Implantation, Intraocular / Q000379:methods* / Q000592:standards; D008027:Light; D008297:Male; D008875:Middle Aged; D014792:Visual Acuity / Q000502:physiology
D000180:Acrylic Resins